Get started
Author

Koji Nakamura

Observed name: Nakamura, Koji
ORCID: 0009-0007-7761-3795
Observed ORCID: 0009-0007-7761-3795
OpenAlex ID: A5034996869
Novel tri-specific tribodies induce strong T cell activation and anti-tumor effects in vitro and in vivo
2022 · Margherita Passariello, Asami Yoshioka, et al. · Journal of Experimental & Clinical Cancer Research · 20
PDF
Tri-specific tribodies targeting 5T4, CD3, and immune checkpoint drive stronger functional T-cell responses than combinations of antibody therapeutics
2025 · Margherita Passariello, Lorenzo Manna, et al. · Cell Death Discovery · 16
PDF
Novel Bi-Specific Immuno-Modulatory Tribodies Potentiate T Cell Activation and Increase Anti-Tumor Efficacy
2022 · Margherita Passariello, Asami Yoshioka, et al. · International Journal of Molecular Sciences · 12
PDF
A Comparison of the Antitumor Efficacy of Novel Multi-Specific Tribodies with Combinations of Approved Immunomodulatory Antibodies
2023 · Lorenzo Manna, Rosa Rapuano Lembo, et al. · Cancers · 6
PDF
A Novel Glycoengineered Humanized Antibody Targeting DLK1 Exhibits Potent Anti-Tumor Activity in DLK1-Expressing Liver Cancer Cell Xenograft Models
2024 · Koji Nakamura, Kota Takahashi, et al. · International Journal of Molecular Sciences · 4
PDF
Works count: 7
Citation count: 58
H-index: 4
I10-index: 3
Year
Topic
Type